| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 129,850 | 03 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | 03 Jan 2023 | 1 | $0 | 4 | Chief Financial Officer | 04 Jan 2023, 15:30 |
| GLUE | Monte Rosa Therapeutics, Inc. | 01 Mar 2022 | 1 | $0 | 4 | Chief Financial Officer | 02 Mar 2022, 17:47 |
| GLUE | Monte Rosa Therapeutics, Inc. | 23 Jun 2021 | 0 | $0 | 3 | Chief Financial Officer | 23 Jun 2021, 20:50 |
| GLUE | Monte Rosa Therapeutics, Inc. | 12 Apr 2021 | 2 | $0 | 4 | Chief Financial Officer | 25 Jun 2021, 17:01 |